BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ONC BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

Post-Mkt 08-06 16:31:34 EDT

329.80

+2.27

+0.69%

盘后329.80

+0.000.00%

16:15 EDT

High333.87	Low326.13	Vol264.38K
Open330.27	D1 Closing327.53	Amplitude2.36%
Mkt Cap37.60B	Tradable Cap28.26B	Total Shares114.00M
T/O87.16M	T/O Rate0.31%	Tradable Shares85.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":329.8,"timestamp":1786046400000,"preClose":327.53,"halted":0,"volume":264380,"hourTrading":{"tag":"盘后","latestPrice":329.8,"preClose":329.8,"latestTime":"16:15 EDT","volume":2472,"amount":815278.00944,"timestamp":1786047320620,"change":0,"changeRate":0,"amplitude":0.000606},"delay":0,"changeRate":0.006930662840045306,"floatShares":85693500,"shares":113999999,"eps":4.404108,"marketStatus":"Post-Mkt","change":2.27,"latestTime":"08-06 16:31:34 EDT","open":330.27,"high":333.87,"low":326.13,"amount":87155789,"amplitude":0.023631,"askPrice":333,"askSize":4,"bidPrice":323.43,"bidSize":6,"shortable":3,"etf":0,"ttmEps":4.404108,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786060800000},"marketStatusCode":4,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":327.53,"preHourTrading":{"tag":"盘前","latestPrice":327.53,"preClose":327.53,"latestTime":"08:16 EDT","volume":198,"amount":65419.2792,"timestamp":1786018606286,"change":0,"changeRate":0,"amplitude":0.031051},"postHourTrading":{"tag":"盘后","latestPrice":329.8,"preClose":329.8,"latestTime":"16:15 EDT","volume":2472,"amount":815278.00944,"timestamp":1786047320620,"change":0,"changeRate":0,"amplitude":0.000606},"volumeRatio":0.784314,"impliedVol":0.3583,"impliedVolPercentile":0.0319},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"2657965623","title":"BeOne Medicines Shares Trading At Discount To Fair Value, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657965623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657965623?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:41","pubTimestamp":1786034463,"startTime":"0","endTime":"0","summary":"BeOne Medicines  shares are trading at a discount to the company's fair value, and investors are overindexing on risks to the Brukinsa franchise, RBC said in a note.The brokerage said the investors are \"not ascribing credit to the solid tumor work - and we would be buyers into 2H26.\"RBC said it likes the company's strong commercial performance with beats across the board on revenue and EPS as evidence of sustainable heme-onc leadership.The company also said Brukinsa continues to grow, with additional label expansion opportunities supporting long-term picture, adding that it looked very impressive, with $1.25 billion in revenue.RBC said that compared with its estimate of $1.23 billion and the Street estimate of $1.20 billion, driven by new patients, improving duration of therapy, and better adherence.RBC maintained a an outperform rating and lowered price target to $450 from $451.Price: 326.88, Change: -0.65, Percent Change: -0.20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","MDCO","BK4139","BK4585","ONC","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657249639","title":"Beone Medicines : Leerink Partners Raises Target Price to $387 from $377","url":"https://stock-news.laohu8.com/highlight/detail?id=2657249639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657249639?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:23","pubTimestamp":1786019014,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4431SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","688235","BK4526","BK4588","BK0239","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689351","title":"Barclays Remains a Buy on BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657689351?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:57","pubTimestamp":1786006621,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on BeOne Medicines today and set a price target of $407.00. According to TipRanks, Darout is ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONC","BK4588","BK4585","MDCO","BK4139","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502079","title":"Beone Medicines : TD Cowen Raises Target Price to $454 from $424","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502079?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:25","pubTimestamp":1785997523,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688235","BK4139","BK4526","BK4588","BK0239","ONC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143571336","title":"Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1143571336","media":"Deep News","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143571336?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:30","pubTimestamp":1785987038,"startTime":"0","endTime":"0","summary":"Beone Medicines (06160.HK) has delivered a standout financial report, reinforcing the strong momentum in the innovative drug sector. Following the impressive results from CXO leader WuXi AppTec, the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU2328871848.SGD","BK4588","BK4139","LU1770034418.SGD","LU1303224171.USD","BK4585","159316","VXUS","FLHK","LU0588546209.SGD","520880","LU1719994722.HKD","LU1251922891.USD","ONC","06160","BK1161","BK0239","KURE","BK1500","BK1583","LU1969619763.USD","BK4526","BK1588","KCAI","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174657246","title":"Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1174657246","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174657246?lang=en_us&edition=fundamental","pubTime":"2026-08-06 09:11","pubTimestamp":1785978684,"startTime":"0","endTime":"0","summary":"Major DevelopmentsCSPC Pharmaceutical Group (01093) has signed a joint venture agreement with AstraZeneca to deepen their strategic collaboration through the establishment of a new company.YouRan...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3M56506.USD","IE00BZ08YS42.EUR","LU1115378108.SGD","LU1720050803.USD","LU0348825331.USD","LU2294711473.HKD","01810","LU2476274720.SGD","LU1969619763.USD","BK1610","LU0345776255.USD","IE0034224299.USD","DRGN","HK0000165453.HKD","LU0169518387.USD","IE00B5MMRT66.SGD","LU0348814723.USD","LU0823426480.USD","LU1960683339.HKD","BK1607","LU0054450605.USD","01093","LU1981816686.USD","LU0456827905.SGD","LU1770034418.SGD","IE0008368742.USD","LU0561508036.HKD","LU0918141705.HKD","LU0463099449.HKD","LU0675040207.SGD","LU0117841782.USD","LU0594300179.USD","BK1212","LU0052750758.USD","LU1323998911.USD","LU0359201612.USD","LU0345775950.USD","LU1868838027.USD","BK1549","LU0594300419.USD","LU2152927971.USD","LU0531970944.HKD","LU1956131251.USD","LU0143863198.USD","LU0823397103.USD","LU0823413660.USD","LU0823426308.USD","IE00B543WZ88.USD","LU0797268264.HKD","BK1523","IE00B0169L03.USD","LU0611395673.USD","IE00BQJZWZ67.USD","BK1161","BK1618","LU0149721374.USD","LU0164872284.USD","LU0327786744.USD","LU1226287792.SGD","LU1719994722.HKD","LU1105468828.SGD","LU2399975544.HKD","LU0348816934.USD","LU0067412154.USD","LU0231483743.USD","09858","LU0531971595.HKD","BK1500","LU0823038988.USD","LU0449515922.USD","LU1481107354.HKD","LU0605514214.HKD","IE0008369823.USD","SG9999003461.SGD","BK4139","BK1515","LU0143863784.USD","BK1587","LU1961090484.USD","SG9999002463.SGD","LU1807302812.USD","LU1251922891.USD","LU0307460666.USD","LU0441854154.USD","IE00BWDBJ730.SGD","BK4585","LU0417516902.SGD","LU0499858438.USD","LU0620787316.HKD","LU0700851271.USD","IE00BZ08YR35.GBP","LU0082770016.SGD","IE00B031HY20.USD","LU0235996351.USD","LU2097828557.USD","LU0823413587.USD","LU0315179316.USD","BK1193","LU2039709279.SGD","LU1226287529.USD","BK4526","LU2476274308.USD","LU2087589342.USD","LU1008478684.HKD","LU0634319403.HKD","LU2097828474.EUR","LU0359202008.SGD","LU2097828631.EUR","LU1303224171.USD","LU0417516738.SGD","LU0540923850.HKD","LU0164880469.USD","LU0880133367.SGD","LU0164939612.USD","LU1794554557.SGD","LU1282648689.USD","LU0823041008.USD","LU2097828805.USD","LU0348827113.USD","BK1237","LU0211977185.USD","LU0572944931.SGD","LU0072913022.USD","LU0320764599.SGD","LU0326950275.SGD","LU1226288253.USD","LU1813983027.USD","BK1615","688235","LU0593848301.USD","LU0082770016.USD","KURE","LU0823397285.USD","06160","LU1880383366.USD","LU0244354667.USD","HXXD.SI","LU0918141887.USD","IE00B19Z5X02.USD","LU1993786604.SGD","SG9999001093.SGD","LU0499858602.USD","LU0359201885.HKD","LU2778985437.USD","LU0650527681.SGD","LU0314109678.HKD","LU1226287875.USD","LU0823040885.USD","00220","LU1868837565.USD","LU0254981946.USD","BK1575","LU0140636845.USD","LU0210526637.USD","BK1521","LU2257852520.SGD","LU0348735423.USD","BK4588","BK0239","ONC","LU0871576103.HKD","BK1583","BK1506","LU1328277881.USD","LU0501845795.SGD","BK1589","LU1770036033.HKD","LU1226288170.HKD","SG9999004220.SGD","LU0823039010.USD","LU0456846285.SGD","HK0000286598.CNH","BK1588","LU1880383440.USD","81810","LU1023057109.AUD","LU1808992512.USD","LU0708995583.HKD","LU1152091754.HKD","LU2328871848.SGD","LU2097828714.EUR","LU0449509016.USD","BK1191","LU0051755006.USD","LU0164865239.USD","BK1502","VXUS","MIUmain","IE0032431581.USD","LU0084288322.USD","LU1152091168.USD","LU0640798160.USD","LU1188198961.HKD","LU0214875030.USD","XIACY","LU2226246903.HKD","KCAI","LU0588546209.SGD","IE00BZ08YT58.USD","LU1951186391.HKD","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130410758","title":"Livermore Index of Leading Chinese Stocks Edges Up 0.1% at Market Open","url":"https://stock-news.laohu8.com/highlight/detail?id=1130410758","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130410758?lang=en_us&edition=fundamental","pubTime":"2026-08-05 22:41","pubTimestamp":1785940900,"startTime":"0","endTime":"0","summary":"Silvercorp Metals leads gainers with a 6.86% surge at the opening bell on August 5, as the Livermore index tracking top Chinese concept stocks rose 0.1%.Other notable performers include BEONE...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","SLVR","BK4150","MLCO","SVM","BK4531","06160","BK4139","BK4585","FINV","BK4588","SLVX","BK4505","BK4202","BK4166","BK4210","AS","BK4526","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657285485","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657285485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657285485?lang=en_us&edition=fundamental","pubTime":"2026-08-05 22:00","pubTimestamp":1785938430,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC). Ce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cencora-cor-american-well-amwl-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cencora-cor-american-well-amwl-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1814569148.SGD","BK4139","LU1119994496.HKD","BK4588","LU2237957811.SGD","XBI","MDCO","LABU","LU1084165304.USD","LU1430594728.SGD","XLV","LU0289739699.SGD","HCSG","AMWL","LU0058720904.USD","LU2237957902.USD","BK4175","BK4529","COR","BK4581","BK4585","SGXZ23171101.USD","ONC","SG9999004303.SGD","LU2324357040.USD","BK4137","LU0128526141.USD","BK4167","LU1261432733.SGD","BK4084","BK4526","LU0029874061.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102813061","title":"Major A-Share Developments: Beone Medicines Reports 627% Surge in First-Half Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1102813061","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102813061?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:50","pubTimestamp":1785934242,"startTime":"0","endTime":"0","summary":"Market Focus for Today China Merchants Energy Shipping (601872) announced on August 5th that it plans to construct five new Aframax tankers. Through its wholly-owned subsidiary, Haiming Shipping...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","LU1969619763.USD","LU1719994722.HKD","BK4526","LU1251922891.USD","LU0307460666.USD","ONC","BK4585","BK1500","BK4588","BK1161","LU1770034418.SGD","LU2328871848.SGD","BK4139","399300","LU0588546209.SGD","BK1583","06160","159982","BK0239","BK1588","KURE","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162137602","title":"Beone Medicines Ltd. Increases 2026 Revenue Forecast to Between 44.9 Billion and 46.2 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137602","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137602?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:42","pubTimestamp":1785930133,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd. (688235.SH) has issued a notice announcing revisions to its 2026 operating performance forecast. The company now expects annual revenue for 2026 to fall between 44.9 billion yuan...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2328871848.SGD","ONC","BK1500","BK1583","LU0307460666.USD","BK1161","06160","BK4139","BK4526","BK4585","LU1719994722.HKD","688235","BK0239","BK1588","LU1770034418.SGD","KURE","LU0588546209.SGD","LU1251922891.USD","LU1969619763.USD","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549227","title":"BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549227","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549227?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:36","pubTimestamp":1785929784,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG reports results for the quarter ended June 30 - Earnings SummaryBeOne Medicines AGONC.OQreported quarterly adjusted earnings of $2.05 per share for the quarter ended June 30, higher","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4421LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4585","BK4139","ONC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116587955","title":"Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1116587955","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116587955?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:28","pubTimestamp":1785925729,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd. delivered a strong second-quarter performance, with its core commercial products continuing to expand. The company's revenue, profits, and cash flow all improved simultaneously,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK1500","LU0588546209.SGD","KURE","ONC","BK0239","BK4588","LU1251922891.USD","LU0307460666.USD","LU1969619763.USD","BK1161","LU1303224171.USD","BK1588","LU1719994722.HKD","BK4139","BK1583","LU2328871848.SGD","BK4526","LU1770034418.SGD","BK4585","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138012620","title":"Beone Medicines Reports Record First Half Results with Adjusted Net Income Surge of 111%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138012620","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138012620?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:18","pubTimestamp":1785925103,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd (stock code: 06160) has released its financial results for the second quarter of fiscal year 2026, showcasing robust performance. For the second quarter, the company's global...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","ONC","BK4588","BK4585","BK1588","BK1500","LU0588546209.SGD","LU1969619763.USD","LU1251922891.USD","BK1161","688235","LU1303224171.USD","BK0239","LU0307460666.USD","LU1719994722.HKD","BK4139","BK1583","KURE","BK4526","LU1770034418.SGD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510243","title":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510243","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510243?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:03","pubTimestamp":1785924210,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656321864","title":"BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656321864","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656321864?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:05","pubTimestamp":1785744305,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG <ONC.OQ> expected to post earnings of $1.58 a share - Earnings PreviewBeOne Medicines AGONC.OQ,ONC.Ois expected to  show a rise in quarterly revenue when it reports  results on Augu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","BK4139","BK4526","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655746888","title":"Is BeOne Medicines (ONC) Stock Priced For Perfection On Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2655746888","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655746888?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:17","pubTimestamp":1785410238,"startTime":"0","endTime":"0","summary":"BeOne Medicines stock has delivered a 59.0% return over the past three years, yet the current checks flag it as screening on the expensive side rather than as an obvious bargain.\n\nBeOne Medicines has returned 59.0% over three years, which puts extra focus on whether the current share price still leaves enough value support for new investors.\nFuture revenue and cash flow expectations can support the current valuation, while any setback in execution or higher funding needs could quickly reduce...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-stock-priced-for-perfection-on-earnin","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-stock-priced-for-perfection-on-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ONC","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130711808","title":"Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1130711808","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130711808?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:06","pubTimestamp":1785406019,"startTime":"0","endTime":"0","summary":"Beigene Ltd (HKEX: 06160) has announced a capital increase through the issuance of 866,100 new shares to its wholly-owned subsidiary, BGNC2.This move is authorized under the company's Swiss Articles...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1719994722.HKD","LU1969619763.USD","LU0588546209.SGD","BK0239","BK4139","BK4588","BK1583","BK1161","BK1500","BK1588","LU0307460666.USD","ONC","BK4585","KURE","LU1303224171.USD","LU2328871848.SGD","LU1251922891.USD","06160","LU1770034418.SGD","688235","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655978928","title":"BeOne Medicines Targets Esophageal Cancer With New Tislelizumab Trial in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2655978928","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655978928?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:31","pubTimestamp":1785342709,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is launching a Phase 2 study in Japan to test dif...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-targets-esophageal-cancer-with-new-tislelizumab-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-targets-esophageal-cancer-with-new-tislelizumab-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","BK4585","ONC","BK4588","BK4526","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197431874","title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1197431874","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197431874?lang=en_us&edition=fundamental","pubTime":"2026-07-29 17:11","pubTimestamp":1785316319,"startTime":"0","endTime":"0","summary":"Abstract BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS will post results on August 05, 2026 Post Market; this preview summarizes last quarter’s performance, breaks down segment trends, and highlights...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192093154","title":"Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1192093154","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192093154?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:24","pubTimestamp":1784895881,"startTime":"0","endTime":"0","summary":"The market faced significant headwinds as the heavyweight ChangXin Technology is set to list on the Shanghai Stock Exchange's STAR Market on July 27. Today, A-share turnover fell below 2 trillion...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1212","LU1719994722.HKD","688981","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0414403682.SGD","01093","LU0516422952.EUR","BK1231","BK1170","03986","LU0149534421.HKD","LU0880133367.SGD","IE00BZ08YR35.GBP","02589","LU0326950275.SGD","LU0072913022.USD","LU1130305938.SGD","LU1251922891.USD","BK1237","LU1951186391.HKD","06613","BK1589","LU0228367735.SGD","ONC","LU1226287875.USD","BHKLY","BK1610","LU0516422366.SGD","LU0955669360.SGD","00175","LU0516422440.USD","BK1526","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","LU0708995583.HKD","LU2360107325.USD","BK1614","02513","BK1560","LU1960683339.HKD","01117","LU1282651121.HKD","BK1515","IE0008368742.USD","BK1191","IE00BVYPNP33.GBP","02388","IE00B0JY6N72.USD","LU0314109678.HKD","BK1117","BK1163","BK1161","BK1500","SG9999014674.SGD","03143","BK1539","LU0607220059.USD","LU0359202008.SGD","LU1008478684.HKD","IE00B031HY20.USD","LU0738912210.USD","LU1807302812.USD","LU0359201885.HKD","LU1993786604.SGD","BK1119","LU2328871848.SGD","LU0417516738.SGD","BK1588","LU0307460666.USD","02356","06809","LU1969619763.USD","LU1152091168.USD","EVS.SI","SG9999002828.SGD","LU0163747925.USD","LU1282651048.USD","BK1607","BK1572","LU0067412154.USD","BK1594","LU1152091754.HKD","LU1770034418.SGD","LU0140636845.USD","00981","BK1507","LU0315179316.USD","LU1226288253.USD","BK1129","LU1861214812.USD","LU1226288170.HKD","LU0293314216.USD","82388","SG9999004220.SGD","LU1328277881.USD","LU0593848301.USD","BKEAY","GELYY","BK1587","LU1642822792.SGD","603986","BK1601","LU1861219969.SGD","IE00B5MMRT66.SGD","BK1583","300433","LU1813983027.USD","KURE","HK0000165453.HKD","LU0320764599.SGD","IE00BZ08YT58.USD","LU1303224171.USD","02218","IE0008369823.USD","LU1044875133.USD","LU0955648018.USD","LU1044874839.SGD","688235","BK1233","00189","LU0501845795.SGD","BK1616","00023","BK1511","LU0588546209.SGD","BK1553","LU0348735423.USD","LU0359201612.USD","LU1044876610.USD","LU0516423174.USD","LU0955623706.USD","09863","LU1224444064.USD","06160","LU1211504680.USD","80175","LU2039709279.SGD","LU1328615791.USD","605198","LU0052750758.USD","BK1521","LU1023057109.AUD","LU1226287792.SGD","LU1226287529.USD","LU0516423091.SGD","688008","BK1522"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0584},{"period":"3month","weight":0.0332},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0661},{"period":"ytd","weight":0.0781}],"compareEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.0522},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.2258},{"period":"ytd","weight":0.1289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.363636,"avgChangeRate":0.018832},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.019621},{"month":6,"riseRate":0.454545,"avgChangeRate":0.010403},{"month":7,"riseRate":0.818182,"avgChangeRate":0.143728},{"month":8,"riseRate":0.636364,"avgChangeRate":0.034406},{"month":9,"riseRate":0.6,"avgChangeRate":0.069537},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004517},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","securityTypeName":"DR","adrRate":"1:13"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS,ONC,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票老虎,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票老虎国际,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS行情,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票行情,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股价,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股市,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票价格,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票交易,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票购买,BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction